THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Stock
Total 13F shares
1,639,040
Share change
-205,102
Total reported value
$829,467
Price per share
$0.51
Number of holders
11
Value change
-$93,478
Number of buys
4
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q4 2019

As of 31 Dec 2019, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,639,040 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, WEDBUSH SECURITIES INC, BOOTHBAY FUND MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, Snowden Capital Advisors LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and DEUTSCHE BANK AG\. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.